mitochondrial ceramidase overexpression up-regulates Bcl-2 protein level in K562 cells, probably through its metabolite sphingosine-1-phosphate.
Recently, a mitochondrial ceramidase has been identified and cloned, whose mitochondrial localization strongly suggests the existence of an unexpected mitochondrial pathway of ceramide metabolism that may play a key role in mitochondrial functions, especially in the regulation of apoptosis. To explore the biological effect of mitochondrial ceramidase on cells, pcDNA 3.1/His-CDase plasmid, containing mitochondrial ceramidase cDNA sequence, was transducted into K562 cells mediated by liposome, and G418 was used to screen for positive colonies. A stable transfected K562 cell line was established and named as 'K562TC'. The difference between K562 and K562TC cells in chemotheraputic cytotoxicity response and serum-withdrawal resistance and Bcl-2 protein expression were evaluated by MTT assay, annexin V/PI test, flow cytometry or Western blotting, respectively. The results showed that although survival was comparable between K562 and K562TC cells after exposed to adriamycin, etoposide or arsenious acid, K562TC cells with elevated Bcl-2 protein expression level as identified by FCM or Western blotting revealed stronger resistance to apoptosis induced by serum withdrawal than their parental cells. Inhibition of mitochondrial ceramidase expression in K562TC cells by its specific antisense oligodeoxynucleotide was correlated with a decrease in Bcl-2 protein level. N, N-dimethylsphingosine, a sphingosine kinase inhibitor, depleted intracellular sphingosine-1-phosphate production, also abrogated Bcl-2 protein expression in K562TC cells, while Bcl-2 protein level in K562 cells was up-regulated by exogenous sphingosine-1-phosphate. It is concluded that mitochondrial ceramidase overexpression in K562 cells leads to markedly elevated level of Bcl-2 protein and results in more resistance to serum withdrawal. This effect is initiated not by sphingosine, the direct metabolite of mitochondrial ceramidase, but via sphingosine-1-phosphate, its phosphorylated form. This is the first evidence that mitochondrial ceramidase, through its sphingoid metabolite sphingosine-1-phosphate, up-regulates Bcl-2 protein expression in K562 cells.
Wang
Fu-Xu
FX
Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China. wangfx@hebmu.edu.cn
Dong
Zuo-Ren
ZR
Liu
Ze-Lin
ZL
Pan
Ling
L
Luo
Jian-Min
JM
Zhang
Xue-Jun
XJ
Hao
Hong-Ling
HL
Li
Xiao-Ling
XL
Yang
Jing-Ci
JC
Jiang
Ling-Ling
LL
D000581:Amidohydrolases / Q000502:physiology*; D017209:Apoptosis; D018053:Arsenites / Q000494:pharmacology; D055572:Ceramidases; D004317:Doxorubicin / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D020014:K562 Cells; D008246:Lysophospholipids / Q000502:physiology*; D008928:Mitochondria / Q000201:enzymology*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000502:physiology*; D015854:Up-Regulation
D018053:Arsenites; D008246:Lysophospholipids; D016376:Oligonucleotides, Antisense; D019253:Proto-Oncogene Proteins c-bcl-2; C060506:sphingosine 1-phosphate; D005047:Etoposide; D004317:Doxorubicin; C032793:arsenous acid; D000581:Amidohydrolases; D055572:Ceramidases; D013110:Sphingosine